Alvotech Files Form 6-K with SEC
Ticker: ALVOW · Form: 6-K · Filed: Jul 1, 2024 · CIK: 1898416
| Field | Detail |
|---|---|
| Company | Alvotech (ALVOW) |
| Form Type | 6-K |
| Filed Date | Jul 1, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, corporate-info, regulatory
TL;DR
Alvotech filed a 6-K on 7/1/24 confirming its Luxembourg HQ and 20-F filing status.
AI Summary
Alvotech, a biopharmaceutical company, filed a Form 6-K on July 1, 2024, to report information as a foreign private issuer. The filing confirms Alvotech's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg. The company is required to file annual reports under cover of Form 20-F.
Why It Matters
This filing provides routine corporate information and confirms Alvotech's reporting status with the SEC, which is important for investors tracking the company's regulatory compliance.
Risk Assessment
Risk Level: low — This filing is a routine administrative report and does not contain new financial or operational information that would typically indicate significant risk.
Key Players & Entities
- Alvotech (company) — Registrant
- 001-41421 (company) — SEC File Number
- 20240701 (date) — Filing Date
- 9, Rue de Bitbourg, L-1273 Luxembourg (location) — Principal Executive Office
FAQ
What type of company is Alvotech?
Alvotech is a biopharmaceutical company specializing in biological products, as indicated by its Standard Industrial Classification code [2836].
Where is Alvotech's principal executive office located?
Alvotech's principal executive office is located at 9, Rue de Bitbourg, L-1273 Luxembourg, Grand Duchy of Luxembourg.
What is Alvotech's SEC file number?
Alvotech's SEC file number is 001-41421.
What form does Alvotech file its annual reports under?
Alvotech files its annual reports under cover of Form 20-F.
What is the filing date of this Form 6-K?
This Form 6-K was filed as of and on July 1, 2024.
Filing Stats: 327 words · 1 min read · ~1 pages · Grade level 12.4 · Accepted 2024-07-01 07:47:16
Filing Documents
- f6k_070124.htm (6-K) — 7KB
- exh_991.htm (EX-99.1) — 13KB
- 0001171843-24-003731.txt ( ) — 21KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Alvotech (Registrant) Date: July 1, 2024 /s/ Tanya Zharov Tanya Zharov General Counsel